Earnings call transcript: Spinneys Q1 2026 sees robust revenue growth amid challenges

Spinneys posted Q1 2026 revenue of AED 1,013 million, up 12% year on year, with gross profit rising 8.4% to AED 406 million and profit after tax increasing 2% to AED 87 million despite major supply chain disruption. Profit before tax was essentially flat at AED 101 million, down 0.7%, as the company absorbed sharply higher freight costs and ~AED 7 million of inventory provisions while protecting customer pricing on essential items. Management kept full-year guidance unchanged, reiterated its dividend policy, and highlighted continued store expansion plus new openings in the Philippines and Kuwait.

Analysis

The market is treating this as a chip-sentiment event, but the real signal is that the narrative is being driven by policy/regulatory risk rather than end-demand deterioration. That matters because policy shocks hit the most crowded AI beneficiaries first: semiconductor leaders with premium multiples, high passive ownership, and consensus positioning built on uninterrupted capex. If the scare persists for several sessions, expect the first-order move to remain concentrated in the most expensive AI hardware names, while diversified financials and defensive retailers remain largely insulated.

The more important second-order effect is supply-chain substitution. If tariffs, export controls, or freight disruption raise landed costs, buyers will push procurement toward inventory-rich vendors, local assemblers, and non-U.S. sourcing channels; that can temporarily favor foundries, packaging, and memory suppliers with flexible routing over pure-play AI accelerator exposure. Conversely, any company with short-cycle demand, low customer concentration, and pricing power can absorb input volatility better than consensus expects, which is why earnings resilience in consumer staples/retail should be read as a margin-defense template rather than a growth story.

The contrarian setup is that the selloff may be mechanically larger than the earnings risk. A policy headline can compress multiples faster than fundamentals can change, and the unwind tends to overshoot when systematic funds de-gross the entire semis basket. If the underlying policy signal does not translate into actual order cancellations or capex cuts within 2-6 weeks, the move should mean-revert; the key is whether this is a headline-driven factor rotation or the start of a real demand revision.

Key Decisions for Investors

• Short NVDA tactically into any intraday relief rally; use a 1-3 week horizon and treat this as a multiple-compression trade rather than a fundamentals call. Risk/reward is attractive if policy headlines keep the AI basket under pressure, but cover quickly if the news flow fades.
• Pair long JPM / short NVDA for 2-4 weeks as a relative-value hedge against AI-beta de-risking. JPM should be far less sensitive to the policy headline cycle, while NVDA remains exposed to crowded positioning and index de-grossing.
• Add a small long in PFE only as a defensive ballast, not a conviction growth trade, if the portfolio needs lower beta during semis volatility. The point is to offset factor risk, not to express pharma upside.
• Favor semis with supply-chain optionality over pure AI exposure: rotate from accelerator-centric names into names with broader end-market mix and lower valuation stretch. Use this as a basket trade over the next 1-2 weeks while the policy narrative settles.
• If NVDA stabilizes and reclaims pre-event levels within 5 trading days, buy a short-dated call spread instead of stock for the rebound. That captures mean reversion while capping downside if the policy scare becomes a real earnings revision.